Spots Global Cancer Trial Database for Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma
Official Title: A Retrospective Observational Study of the Effectiveness of Gemcitabine -Docetaxel in Patients With Relapsed Osteosarcoma Who Have Been Treated With HD-IFO in First Line Treatment
Study ID: NCT04651179
Interventions
Study Description
Brief Summary: A retrospective observational study of the effectiveness of gemcitabine - docetaxel in patients with relapsed osteosarcoma who have been treated with HD IFO in first line treatment
Detailed Description:
Keywords
Eligibility
Minimum Age: 4 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Istituto Nazionale Tumori, Milan, Milano, Italy
Fondazione del Piemonte per l' Oncologia IRCCS Candiolo, Candiolo, Turin, Italy
Istituto Ortopedico Rizzoli, Bologna, , Italy
AOUC Azienda Ospedaliero-Universitaria Careggi, Florence, , Italy
IRCCS Istituto Nazionale dei Tumori, Milan, , Italy
Azienda Ospedaliero Universitaria pisana, Pisa, , Italy
IRCCS Istituti Fisioterapici Ospitalieri, Rome, , Italy
AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita, Turin, , Italy
Contact Details
Name: Franca Fagioli, MD
Affiliation: AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
